Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  60 results for ""GLUCAGON-like peptide-1 receptor""

Your Filters

Publication : acta diabetologica Filter by : Subject Sort Order : Relevance
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.

  • Authors : Ciardullo S; Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Milan, Italy. .; Department of Medicine and Rehabilitation, Policlinico di Monza, Via Modigliani 10, 20900, Monza, Italy. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Receptors, Gastrointestinal Hormone*/Receptors, Gastrointestinal Hormone*/Receptors, Gastrointestinal Hormone*/agonists

  • Source: Acta diabetologica [Acta Diabetol] 2024 Aug; Vol. 61 (8), pp. 941-950. Date of Electronic Publication: 2024 Jun 03.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RAs inhibit the activation of the NLRP3 inflammasome signaling pathway to regulate mouse renal podocyte pyroptosis.

  • Authors : Li X; Department of Endocrinology and Metabolic Diseases, Dalian University Affiliated Xinhua Hospital, Dalian, 116021, Liaoning, China.; Jiang X

Subjects: Inflammasomes*/Inflammasomes*/Inflammasomes*/metabolism ; Inflammasomes*/Inflammasomes*/Inflammasomes*/pharmacology ; Podocytes*

  • Source: Acta diabetologica [Acta Diabetol] 2024 Feb; Vol. 61 (2), pp. 225-234. Date of Electronic Publication: 2023 Oct 17.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.

  • Authors : Diallo A; University Montpellier, 80 Avenue Augustin Fliche, 34295, Montpellier Cedex 5, France. .; Carlos-Bolumbu M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Acta diabetologica [Acta Diabetol] 2023 Dec; Vol. 60 (12), pp. 1651-1662. Date of Electronic Publication: 2023 Jul 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?

  • Authors : Menghini R; Departments of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy. .; Casagrande V

Subjects: Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2023 Nov; Vol. 60 (11), pp. 1441-1448. Date of Electronic Publication: 2023 Jul 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.

  • Authors : Oezer K; 5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. .; Kolibabka M

Subjects: Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/drug therapy ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/etiology ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/metabolism

  • Source: Acta diabetologica [Acta Diabetol] 2023 Nov; Vol. 60 (11), pp. 1551-1565. Date of Electronic Publication: 2023 Jul 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus.

  • Authors : Berra C; Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS Multimedica, Milan, Italy. .; Manfrini R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Acta diabetologica [Acta Diabetol] 2023 Sep; Vol. 60 (9), pp. 1257-1266. Date of Electronic Publication: 2023 Jun 04.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy.

  • Authors : Zaitoon H; Pediatric Endocrinology and Diabetes Unit, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, 6 Weizmann St, 64239-06, Tel Aviv, Israel.; Lubetzky R

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Metformin*/Metformin*/Metformin*/therapeutic use ; Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/Muscular Atrophy, Spinal*/drug therapy

  • Source: Acta diabetologica [Acta Diabetol] 2023 Aug; Vol. 60 (8), pp. 1099-1108. Date of Electronic Publication: 2023 May 09.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.

  • Authors : Falcetta P; Department of Clinical and Experimental Medicine, University of Pisa, 56124, Pisa, Italy.; Nicolì F

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Male ; Humans

  • Source: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 53-60. Date of Electronic Publication: 2022 Sep 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

  • Authors : Burlina S; Department of Medicine - DIMED, University of Padua, Padua, Italy.; Dalfrà MG

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Female

  • Source: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 137-138. Date of Electronic Publication: 2022 Sep 22.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.

Subjects: *GLUCAGON receptors; *TYPE 1 diabetes; *GLUCAGON-like peptide-1 receptor

  • Source: Acta Diabetologica. Jan2023, Vol. 60 Issue 1, p19-28. 10p.

Record details

Read More Add to Saved list
×
  • 1-10 of  60 results for ""GLUCAGON-like peptide-1 receptor""